Andere talen Sanofi India Limited NSE India S.E.

Aandelen

SANOFI

INE058A01010

Vertraagde tijd NSE India S.E. Andere beurzen 09:06:49 08-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
8.245 ^INR	-1,53%		-4,95%	+2,24%

15/04	Sanofi India Limited kondigt benoeming aan van Flovie Martins als hoofd bedrijfscommunicatie en maatschappelijk verantwoord ondernemen	CI
28/03	Sanofi India Limited kondigt ontslag aan van Marc-Antoine Lucchini als niet-uitvoerend bestuurder, lid van het Benoemings- en Remuneratiecomité	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sanofi India Limited Announces Appointment of Flovie Martins as Head of Corporate Communications and Corporate Social Responsibility	15/04
Sanofi India Limited Announces Resignation of Marc-Antoine Lucchini as Non-Executive Director from the Board of Directors, Member of the Nomination and Remuneration Committee	28/03
Cipla to Distribute Sanofi's CNS Product Line in India	27/03
Sanofi India Limited, Sanofi Healthcare India Private Limited and Cipla Limited Announce an Exclusive Partnership	26/03
Sanofi India Limited and Emcure Pharmaceuticals Announces Exclusive Distribution Partnership to Broad Broadline Reach of Sanofi's Cardiovascular Brands	13/03
Sanofi India Limited Recommends Final Dividend for the Financial Year Ended 31St December 2023, Payable on or After 24 May 2024	23/02
Sanofi India Limited Declares Interim Dividend for the Financial Year Ended 31St December, 2023, Payable on or After 20 March, 2024	23/02
Sanofi India Limited Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Sanofi India Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	23/02
Sanofi India Limited Appoints Radhika Shah as Head of Legal, Effective 15 January 2024	10/01
Sanofi India appoints Himanshu Bakshi as General Manager for its Consumer Healthcare business	20/12
Sanofi Sees Improvement in Trial Results of Cancer Drug Sarclisa	11/12
Trending : Merck's Multiple Sclerosis Drug Misses Expectations in Late-Stage Trials	06/12
Sanofi India's CFO Steps Down	09/11
Sanofi India Limited Announces the Resignation of Vaibhav Karandikar as Whole-Time Director	08/11
Sanofi India Limited Announces the Resignation of Vaibhav Karandikar as Chief Financial Officer, effective November 30, 2023	08/11
Sanofi India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Sanofi India Limited Appoints Surabhi Kaul as India People Director and Will Be Part of the Senior Management Personnel	17-10-23
Sanofi India Limited Announces Executive Changes	26-09-23
Sanofi India Limited Announces Resignation of Vinita Korti Patil as Senior Legal Director - South Asia, Effective 7 December 2023	14-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sanofi India Limited NSE India S.E.

Aandelen

SANOFI

INE058A01010

Andere talen

Filters